Variant report
Variant | nsv964086 |
---|---|
Chromosome Location | chr4:119338967-119341856 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144735430 | chr4:119338968-119338969 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185445160 | chr4:119338974-119338975 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528390995 | chr4:119339045-119339046 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535436855 | chr4:119339058-119339059 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs370944618 | chr4:119339133-119339134 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188393653 | chr4:119339166-119339167 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541699182 | chr4:119339181-119339182 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1828857 | chr4:119339182-119339183 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs1808022 | chr4:119339208-119339209 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs556894418 | chr4:119339222-119339223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1828856 | chr4:119339227-119339228 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs530909226 | chr4:119339336-119339337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs3896922 | chr4:119339345-119339346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546352195 | chr4:119339367-119339368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553393316 | chr4:119339458-119339459 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573320721 | chr4:119339484-119339485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542246312 | chr4:119339499-119339500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4103597 | chr4:119339515-119339516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs3879776 | chr4:119339569-119339570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs71608371 | chr4:119339691-119339692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs531124020 | chr4:119339767-119339768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544761463 | chr4:119339913-119339914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564550691 | chr4:119339923-119339924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532064782 | chr4:119339950-119339951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4103612 | chr4:119340054-119340055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565335863 | chr4:119340062-119340063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570529012 | chr4:119340064-119340065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528034062 | chr4:119340077-119340078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533190988 | chr4:119340139-119340140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574863506 | chr4:119340163-119340164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181218832 | chr4:119340164-119340165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4001535 | chr4:119340192-119340193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568311096 | chr4:119340203-119340204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4001536 | chr4:119340269-119340270 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
35 | rs536136800 | chr4:119340287-119340288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549321029 | chr4:119340318-119340319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569387784 | chr4:119340321-119340322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557098596 | chr4:119340399-119340400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570594333 | chr4:119340403-119340404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200318414 | chr4:119340470-119340471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71608374 | chr4:119340504-119340505 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs185721854 | chr4:119340511-119340512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71608375 | chr4:119340514-119340515 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs573383062 | chr4:119340518-119340519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535811268 | chr4:119340553-119340554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1843662 | chr4:119340679-119340680 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576989188 | chr4:119340691-119340692 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4001513 | chr4:119340692-119340693 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs544615123 | chr4:119340718-119340719 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200844818 | chr4:119340740-119340741 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:119337400-119339200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:119337600-119339400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
3 | chr4:119338000-119339200 | Enhancers | HMEC | breast |
4 | chr4:119338000-119339400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:119338000-119339400 | Enhancers | NHEK | skin |
6 | chr4:119338400-119339000 | Enhancers | HSMMtube | muscle |
7 | chr4:119338400-119339400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:119338600-119339000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr4:119338600-119339200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
10 | chr4:119338600-119339200 | Enhancers | Liver | Liver |
11 | chr4:119338600-119339800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr4:119338800-119339200 | Bivalent Enhancer | Osteobl | bone |
13 | chr4:119339200-119339400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr4:119339200-119340600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr4:119340600-119340800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr4:119340600-119341000 | Active TSS | Osteobl | bone |
17 | chr4:119340800-119345400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |